$3.19 Billion is the total value of PFM Health Sciences, LP's 84 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 44.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $165,604,000 | +2.2% | 901,441 | -14.9% | 5.19% | +4.9% |
| HZNP | HORIZON THERAPEUTICS PUB L | $148,639,000 | +1.7% | 1,587,348 | 0.0% | 4.66% | +4.4% | |
| OM | Sell | OUTSET MED INC | $148,276,000 | -9.5% | 2,966,712 | -1.5% | 4.65% | -7.1% |
| LLY | LILLY ELI & CO | $120,602,000 | +22.9% | 525,455 | 0.0% | 3.78% | +26.1% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $108,610,000 | +5.8% | 1,116,004 | +5.7% | 3.40% | +8.6% |
| ABBV | ABBVIE INC | $104,397,000 | +4.1% | 926,823 | 0.0% | 3.27% | +6.8% | |
| RCUS | ARCUS BIOSCIENCES INC | $96,062,000 | -2.2% | 3,498,260 | 0.0% | 3.01% | +0.4% | |
| MYGN | Buy | MYRIAD GENETICS INC | $94,466,000 | +14.1% | 3,089,152 | +13.6% | 2.96% | +17.1% |
| IQV | IQVIA HLDGS INC | $86,730,000 | +25.5% | 357,916 | 0.0% | 2.72% | +28.8% | |
| HCA | HCA HEALTHCARE INC | $80,733,000 | +9.8% | 390,507 | 0.0% | 2.53% | +12.6% | |
| SGEN | New | SEAGEN INC | $76,254,000 | – | 482,985 | +100.0% | 2.39% | – |
| CNC | Buy | CENTENE CORP DEL | $76,246,000 | +123.5% | 1,045,473 | +95.9% | 2.39% | +129.4% |
| AVTR | Sell | AVANTOR INC | $73,849,000 | +14.5% | 2,079,657 | -6.7% | 2.32% | +17.5% |
| UHS | UNIVERSAL HLTH SVCS INCcl b | $71,311,000 | +9.8% | 487,000 | 0.0% | 2.24% | +12.7% | |
| NVRO | Sell | NEVRO CORP | $69,407,000 | +11.8% | 418,645 | -5.9% | 2.18% | +14.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $68,470,000 | +103.8% | 2,807,310 | +115.6% | 2.15% | +109.2% |
| MCK | MCKESSON CORP | $68,126,000 | -1.9% | 356,231 | 0.0% | 2.14% | +0.6% | |
| HUM | HUMANA INC | $63,046,000 | +5.6% | 142,406 | 0.0% | 1.98% | +8.4% | |
| UNH | UNITEDHEALTH GROUP INC | $58,182,000 | +7.6% | 145,295 | 0.0% | 1.82% | +10.5% | |
| EW | EDWARDS LIFESCIENCES CORP | $53,132,000 | +23.8% | 513,005 | 0.0% | 1.66% | +27.1% | |
| ICUI | Sell | ICU MED INC | $52,625,000 | -11.9% | 255,708 | -12.0% | 1.65% | -9.6% |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $48,140,000 | -3.7% | 48,150,000 | 0.0% | 1.51% | -1.2% | ||
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $47,834,000 | +1.0% | 45,910,000 | 0.0% | 1.50% | +3.7% | ||
| DHR | DANAHER CORPORATION | $47,148,000 | +19.2% | 175,690 | 0.0% | 1.48% | +22.4% | |
| GH | Buy | GUARDANT HEALTH INC | $46,463,000 | +49.0% | 374,131 | +83.1% | 1.46% | +52.8% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $46,367,000 | -12.6% | 287,046 | -7.3% | 1.45% | -10.4% |
| GILD | Sell | GILEAD SCIENCES INC | $45,902,000 | -33.9% | 666,601 | -38.0% | 1.44% | -32.2% |
| BIIB | Buy | BIOGEN INC | $45,802,000 | +60.5% | 132,272 | +29.6% | 1.44% | +64.7% |
| THC | Buy | TENET HEALTHCARE CORP | $44,687,000 | +52.5% | 667,073 | +18.4% | 1.40% | +56.5% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $43,541,000 | +3.0% | 1,912,188 | -6.9% | 1.36% | +5.7% |
| WAT | Buy | WATERS CORP | $40,655,000 | +26.5% | 117,634 | +4.0% | 1.27% | +29.9% |
| BAX | Buy | BAXTER INTL INC | $36,923,000 | -4.5% | 458,667 | +0.0% | 1.16% | -2.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $36,828,000 | +11.0% | 2,144,881 | +44.5% | 1.15% | +13.9% |
| PEN | Buy | PENUMBRA INC | $36,658,000 | +82.2% | 133,759 | +79.9% | 1.15% | +87.1% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $34,945,000 | -5.4% | 2,182,684 | +5.6% | 1.10% | -2.9% |
| HRTX | Buy | HERON THERAPEUTICS INC | $34,129,000 | +0.3% | 2,199,057 | +4.8% | 1.07% | +3.0% |
| CYTK | Buy | CYTOKINETICS INC | $33,386,000 | -6.6% | 1,687,012 | +9.8% | 1.05% | -4.1% |
| MRNA | New | MODERNA INCput | $33,132,000 | – | 141,000 | +100.0% | 1.04% | – |
| NVAX | Sell | NOVAVAX INC | $31,656,000 | -13.0% | 149,104 | -25.7% | 0.99% | -10.8% |
| ICLR | Buy | ICON PLC | $29,813,000 | +130.5% | 144,227 | +119.0% | 0.93% | +136.5% |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $29,459,000 | +0.2% | 2,990,770 | 0.0% | 0.92% | +2.8% | |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $28,856,000 | +26.6% | 178,222 | -37.3% | 0.90% | +29.9% |
| BFLY | BUTTERFLY NETWORK INC | $26,474,000 | -14.0% | 1,828,311 | 0.0% | 0.83% | -11.7% | |
| CANO | New | CANO HEALTH INC | $25,341,000 | – | 2,094,279 | +100.0% | 0.79% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $23,565,000 | – | 345,523 | +100.0% | 0.74% | – |
| JNCE | JOUNCE THERAPEUTICS INC | $22,187,000 | -33.8% | 3,262,833 | 0.0% | 0.70% | -32.1% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $22,044,000 | +2.5% | 193,386 | +8.1% | 0.69% | +5.2% |
| IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $21,372,000 | -3.3% | 23,000,000 | 0.0% | 0.67% | -0.7% | ||
| MOH | MOLINA HEALTHCARE INC | $17,736,000 | +8.3% | 70,088 | 0.0% | 0.56% | +11.2% | |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $17,570,000 | – | 34,829 | +100.0% | 0.55% | – |
| ZLAB | ZAI LAB LTDadr | $17,588,000 | +32.6% | 99,375 | 0.0% | 0.55% | +36.0% | |
| LH | New | LABORATORY CORP AMER HLDGS | $17,555,000 | – | 63,640 | +100.0% | 0.55% | – |
| CNC | New | CENTENE CORP DELcall | $16,409,000 | – | 225,000 | +100.0% | 0.51% | – |
| CNST | CONSTELLATION PHARMCETICLS I | $15,875,000 | +44.5% | 469,664 | 0.0% | 0.50% | +48.7% | |
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $15,825,000 | -24.1% | 606,800 | +2.8% | 0.50% | -22.0% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $15,455,000 | +16.4% | 3,627,900 | +45.0% | 0.48% | +19.2% |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $14,685,000 | – | 602,100 | +100.0% | 0.46% | – |
| NTLA | New | INTELLIA THERAPEUTICS INCcall | $13,762,000 | – | 85,000 | +100.0% | 0.43% | – |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $12,495,000 | -69.0% | 208,600 | -74.3% | 0.39% | -68.2% |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $12,359,000 | – | 443,595 | +100.0% | 0.39% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $11,208,000 | – | 708,927 | +100.0% | 0.35% | – |
| New | GALAPAGOS NVspon adr | $10,406,000 | – | 177,934 | +100.0% | 0.33% | – | |
| FSII | FS DEVELOPMENT CORP II | $10,000,000 | +0.4% | 1,000,000 | 0.0% | 0.31% | +3.0% | |
| PMVP | New | PMV PHARMACEUTICALS INC | $9,849,000 | – | 288,334 | +100.0% | 0.31% | – |
| STTK | SHATTUCK LABS INC | $9,474,000 | +3.1% | 326,813 | 0.0% | 0.30% | +5.7% | |
| INNV | INNOVAGE HLDG CORP | $9,157,000 | -17.4% | 429,699 | 0.0% | 0.29% | -15.1% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $8,324,000 | – | 455,374 | +100.0% | 0.26% | – |
| NOVAVAX INCnote 3.750% 2/0 | $7,612,000 | +8.8% | 4,250,000 | 0.0% | 0.24% | +11.7% | ||
| VECT | New | VECTIVBIO HLDG AG | $7,125,000 | – | 611,074 | +100.0% | 0.22% | – |
| HOWL | New | WEREWOLF THERAPEUTICS INC | $6,976,000 | – | 400,000 | +100.0% | 0.22% | – |
| ATHA | Buy | ATHIRA PHARMA INC | $6,945,000 | -19.7% | 678,247 | +44.2% | 0.22% | -17.4% |
| KNTE | KINNATE BIOPHARMA INC | $6,153,000 | -25.3% | 264,293 | 0.0% | 0.19% | -23.1% | |
| LUNG | PULMONX CORP | $6,026,000 | -3.5% | 136,576 | 0.0% | 0.19% | -1.0% | |
| FLDM | FLUIDIGM CORP DEL | $6,040,000 | +36.3% | 980,505 | 0.0% | 0.19% | +40.0% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $5,815,000 | -29.2% | 188,243 | 0.0% | 0.18% | -27.5% | |
| ONEM | 1LIFE HEALTHCARE INC | $5,676,000 | -15.4% | 171,689 | 0.0% | 0.18% | -13.2% | |
| CYTK | New | CYTOKINETICS INCcall | $5,316,000 | – | 268,600 | +100.0% | 0.17% | – |
| BLSA | BCLS ACQUISITION CORP | $4,887,000 | -0.4% | 464,103 | 0.0% | 0.15% | +2.0% | |
| JYAC | JIYA ACQUISITION CORP | $4,613,000 | +1.0% | 464,103 | 0.0% | 0.14% | +4.3% | |
| CERT | Sell | CERTARA INC | $4,052,000 | -42.5% | 143,028 | -44.6% | 0.13% | -40.9% |
| OSH | OAK STR HEALTH INC | $3,939,000 | +7.9% | 67,250 | 0.0% | 0.12% | +10.8% | |
| NEVRO CORPnote 2.750% 4/0 | $3,480,000 | +14.8% | 2,000,000 | 0.0% | 0.11% | +17.2% | ||
| DOCS | New | DOXIMITY INCcl a | $1,746,000 | – | 30,000 | +100.0% | 0.06% | – |
| ALNA | ALLENA PHARMACEUTICALS | $370,000 | -6.3% | 284,285 | 0.0% | 0.01% | 0.0% | |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORPcall | $0 | – | -500,000 | -100.0% | -0.15% | – |
| HRTX | Exit | HERON THERAPEUTICS INCcall | $0 | – | -324,100 | -100.0% | -0.16% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -329,274 | -100.0% | -0.22% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -232,216 | -100.0% | -0.24% | – |
| SPRB | Exit | SPRUCE BIOSCIENCES INC | $0 | – | -489,631 | -100.0% | -0.25% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INCcall | $0 | – | -246,000 | -100.0% | -0.26% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -82,534 | -100.0% | -0.30% | – |
| CERN | Exit | CERNER CORP | $0 | – | -139,569 | -100.0% | -0.31% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -46,889 | -100.0% | -0.31% | – |
| ICUI | Exit | ICU MED INCcall | $0 | – | -68,800 | -100.0% | -0.43% | – |
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -81,000 | -100.0% | -0.45% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -56,442 | -100.0% | -0.62% | – |
| PODD | Exit | INSULET CORP | $0 | – | -118,382 | -100.0% | -0.94% | – |
| ARKK | Exit | ARK ETF TRput | $0 | – | -258,700 | -100.0% | -0.95% | – |
| DXCM | Exit | DEXCOM INCcall | $0 | – | -87,200 | -100.0% | -0.96% | – |
| JWS | Exit | JAWS ACQUISITION CORP | $0 | – | -2,526,594 | -100.0% | -1.02% | – |
| PPD | Exit | PPD INC | $0 | – | -1,096,492 | -100.0% | -1.27% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -350,000 | -100.0% | -1.45% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -408,500 | -100.0% | -1.88% | – |
| XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -1,585,000 | -100.0% | -5.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.